- Home
- REKR vs MIST Comparison
REKR vs MIST Comparison
Compare REKR & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REKR
- MIST
- Stock Information
- Founded
- REKR 2017
- MIST 2003
- Country
- REKR United States
- MIST Canada
- Employees
- REKR N/A
- MIST N/A
- Industry
- REKR Telecommunications Equipment
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- REKR Telecommunications
- MIST Health Care
- Exchange
- REKR Nasdaq
- MIST Nasdaq
- Market Cap
- REKR 151.6M
- MIST 163.2M
- IPO Year
- REKR N/A
- MIST N/A
- Fundamental
- Price
- REKR $2.31
- MIST $1.80
- Analyst Decision
- REKR
- MIST Strong Buy
- Analyst Count
- REKR 0
- MIST 3
- Target Price
- REKR N/A
- MIST $6.33
- AVG Volume (30 Days)
- REKR 9.0M
- MIST 1.4M
- Earning Date
- REKR 11-13-2025
- MIST 11-11-2025
- Dividend Yield
- REKR N/A
- MIST N/A
- EPS Growth
- REKR N/A
- MIST N/A
- EPS
- REKR N/A
- MIST N/A
- Revenue
- REKR $45,380,000.00
- MIST N/A
- Revenue This Year
- REKR $10.03
- MIST N/A
- Revenue Next Year
- REKR $24.80
- MIST N/A
- P/E Ratio
- REKR N/A
- MIST N/A
- Revenue Growth
- REKR 7.05
- MIST N/A
- 52 Week Low
- REKR $0.62
- MIST $0.63
- 52 Week High
- REKR $3.42
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- REKR 48.73
- MIST 40.52
- Support Level
- REKR $2.56
- MIST $1.76
- Resistance Level
- REKR $2.60
- MIST $1.96
- Average True Range (ATR)
- REKR 0.25
- MIST 0.09
- MACD
- REKR -0.09
- MIST -0.02
- Stochastic Oscillator
- REKR 5.93
- MIST 13.79
About REKR Rekor Systems Inc.
Rekor Systems Inc is a United States-based company. The company is engaged in providing real-time roadway intelligence through AI-driven decisions. The firm uses artificial intelligence to analyze video streams and transform them into AI-driven decisions. The company's technology and machine learning models power all solutions, including Rekor Command for transportation management, Rekor Discover for urban mobility, and Rekor Scout for public safety, and commercial use. Its geographical segments are the United States and Others, of which a majority of its revenue comes from the United States.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).